Crystallization Process Development

As a world leader in pharmaceutical services, Almac delivers bespoke crystallization development work programs for small molecules and peptides designed to provide a robust, scaleable, and transferrable crystallization procedure to help accelerate clinical development and minimize risk in any downstream activities by eliminating batch-to-batch variability. The goals of typical studies include:

  • Impurity rejection / purge studies
  • Kinetics of nucleation and growth
  • Polymorphic form control
  • Maximizing yield
  • Morphology engineering studies
  • Particle size control
  • Bulk density and powder flow improvement
  • Milling and micronisation studies
  • Isolation and drying processes
  • Control over residual solvent
  • Seeding protocol

Read the full article below to learn more.

View Resource

Download here instantly

This website uses cookies. By continuing to browse the site, you are agreeing to our use of cookies